Financing, Equity Capital Markets

Seres Therapeutics, Inc.

08/20
|
$225.8 Million
Piper Sandler served as bookrunner for Seres Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma